GSKCONS

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding Board meeting held on February 06, 2020.

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding Board meeting held on November 07, 2019.

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding Board meeting held on August 01, 2019.

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding Outcome of Board Meeting held on May 10, 2019.

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding Board meeting held on May 11, 2018.

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding Board meeting held on March 28, 2018.

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange that the Board of Directors, at its meeting held on February 13, 2017 , the tenure of Mr. Subodh Bhargava as a Non Executive Chairman of the Company has been extended further for a period of one year with effect from March 31, 2017 till March 31, 2018.

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on May 01, 2013, has noted the withdrawal of nomination by Horlicks Limited of Mr.Simon Scarff as the Director of the Company and as the Chairman of the Board w.e.f. close of business hours as on April 30, 2013 & accepted the resignation of Mr.Subodh Bhargava as an elected Director. The Board appointed Ms.Ireena Vittal as a Director of the Company, in the casual vacancy caused by the resignation of Mr.Subodh Bhargava. Pursuant to Article 97A of the Articles of As

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange that at the Board Meeting held on Tuesday, April 9, 2013 Mr. Simon Scarff, Chairman of the Board of Directors, has expressed his desire to step down as the Chairman of the Company w.e.f. close of business hours on April 30, 2013.

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on February 15, 2013 has transacted the following:(1) Re-appointed Mr. Zubair Ahmed as Managing Director of the Company for the period from June 01, 2013 to May 31, 2017. Mr. Zubair Ahmed's terms of appointment and remuneration are subject to the approval of the shareholders.(2). The Board also approved the change in Financial Year of the Company from Calendar Year to Financial Year w.e.f. January 01, 2013 to March 31, 2014 and thereafter the Financial Year will

Glaxosmithkline Consumer Healthcare Limited has informed the Exchange that the Board of Directors of the Company at its meeting of the Company held on February 06, 2012 has appointed Mr. Jaiboy John Phillips as a Wholetime Director of the Company, w.e.f. February 06, 2012, in the casual vacancy caused by the resignation of Mr. Praveen K Gupta, Director - Operations.

Glaxosmithkline Consumer Healthcare Limited has informed the Exchange that the Board of Directors has re-appointed Mr. Zubair Ahmed as Managing Director of the Company for the period from January 01, 2012 to May 31, 2013 as a Nominee of Horlicks Ltd., the Promoters of the Company. Mr. Zubair Ahmed's terms of appointment and remuneration are subject to the approval of the shareholders.

Glaxosmithkline Consumer Healthcare Limited has informed the Exchange that the Board of Directors at a meeting held on July 29, 2009. The following items which were also approved at the board meeting: 1) Proposed appointment of Mr. Zubair Ahmed as Non-Executive Director on the Board of M/s. Raheja Builders Private Ltd. 2) Appointment of Mr. Ramakrishnan Subramanian, the CFO of the Company, as Wholetime Director w.e.f. August 1, 2009 subsequent to his nomination by Horlicks Ltd., under Article 97-A of the Articles of Association of the Company. 3) Investment of up to Rs. 200 Crores for enhancem